CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,800 | -47.6% | 10,000 | 0.0% | 0.02% | -40.7% |
| Q2 2023 | $35,900 | +6.5% | 10,000 | 0.0% | 0.03% | +3.8% |
| Q1 2023 | $33,700 | +117.4% | 10,000 | 0.0% | 0.03% | +116.7% |
| Q4 2022 | $15,500 | +10.7% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $14,000 | -36.4% | 10,000 | 0.0% | 0.01% | -33.3% |
| Q2 2022 | $22,000 | -31.2% | 10,000 | 0.0% | 0.02% | -14.3% |
| Q1 2022 | $32,000 | -23.8% | 10,000 | 0.0% | 0.02% | -22.2% |
| Q4 2021 | $42,000 | -48.1% | 10,000 | 0.0% | 0.03% | -55.0% |
| Q3 2021 | $81,000 | +6.6% | 10,000 | 0.0% | 0.06% | +7.1% |
| Q2 2021 | $76,000 | -12.6% | 10,000 | 0.0% | 0.06% | -18.8% |
| Q1 2021 | $87,000 | +8.8% | 10,000 | 0.0% | 0.07% | 0.0% |
| Q4 2020 | $80,000 | 0.0% | 10,000 | 0.0% | 0.07% | -4.2% |
| Q3 2020 | $80,000 | -19.2% | 10,000 | 0.0% | 0.07% | -33.9% |
| Q2 2020 | $99,000 | +28.6% | 10,000 | 0.0% | 0.11% | +17.2% |
| Q1 2020 | $77,000 | +102.6% | 10,000 | 0.0% | 0.09% | +126.8% |
| Q4 2019 | $38,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |